APOB and metabolic dysfunction-associated steatotic liver disease: Despite higher VLDL-TG secretion in patients with hepatic steatosis compared to healthy individuals, VLDL-apoB100 secretion was unchanged, suggesting that NAFLD patients do not secrete additional, but instead larger and more triglyceride-rich, VLDL particles [110].